Key Dates

Related Announcements

PAR-17-214 Limited Competition: Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (U01)

PAR-17-287 NIA Academic Leadership Career Award (K07)

PAR-17-290 NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25)

PAR-18-513 Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

PAR-18-524 Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32)

PAR-18-715 NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer's Disease Patient Registry Cooperative Agreement Awards (U01 - Clinical Trial Not Allowed)

PAR-18-749 Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed)

PAR-18-820 Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

PAR-18-878 Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)

PAR-18-889 Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed)

PAR-18-890 Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed)

PA-19-230 Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required)

PAR-19-234 Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed)

PAR-19-269 Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed)

PAR-19-288 Limited Competition: NIA Genome Center for Alzheimer's Disease (U54 Clinical Trial Not Allowed)

PAR-19-302 NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)

PAR-19-314 NIA Program Project Applications (P01 Clinical Trial Optional)

PAR-19-338 Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed)

PAR-19-374 Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)

PAR-19-394 Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed)

PAR-20-070 Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 Clinical Trial Optional)

PAR-20-071 Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)

PAR-20-095 Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed)

PAR-20-099 Harmonization of Alzheimer’s Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed)

PAR-20-110 National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed)

PAR-20-156 Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional)

RFA-AG-21-001 NIA Research Centers Collaborative Network (RCCN) (U24 Clinical Trial Optional)

RFA-AG-21-002 Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed)

RFA-AG-21-005 Limited Competition: National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed)

RFA-AG-21-006 Alzheimer’s Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed)

RFA-AG-21-008 National Longitudinal Study of Adolescent to Adult Health (Add Health) Wave 6 (U01 Clinical Trial Not Allowed)

RFA-AG-21-010 Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed)

RFA-AG-21-012 Resource Networks for Protein Polymorphisms in Alzheimer’s Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)

RFA-AG-21-013 Prodromal a-Synucleinopathies Consortium (U19 Clinical Trial Optional)

RFA-AG-21-014 National Alzheimer's Coordinating Center (NACC) (U24 Clinical Trial Not Allowed)

RFA-AG-21-007 Leadership Award for Alzheimer's Disease and Related Dementias Research (R35 Clinical Trial Not Allowed)

Issued by

National Institute on Aging (NIA)

Purpose

Late applications will be accepted by 5:00 PM local time up to two weeks after the application due date for the NIA-specific FOAs listed below. Institutions do not need to request advance permission. While a cover letter may be provided, it is not required to take advantage of this flexibility. NIH’s late application submission policy for institutions closed due to the effects of COVID-19 (NOT-OD-20-082) still applies to these FOAs for institutions that are not able to submit within the two-week window. However, note that late applications submitted per NOT-OD-20-082 are considered on a case-by-case basis.

All other FOAs will follow the standard NIH late application policies, including considerations related to the emergency declaration for COVID-19 (NOT-OD-20-082)

Inquiries

Please direct all inquiries to:

Ramesh Vemuri, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9666
Email: [email protected]